via Johnson & Johnson agrees to pay $181 million to settle multistate litigation over improper marketing:
"Johnson & Johnson will pay $181 million to resolve claims by 36 states that it improperly advertised the antipsychotic drugs Risperdal and Invega, New York Attorney General Eric Schneiderman and the company said.
J&J and its Janssen subsidiary settled charges that it promoted the drugs from 1998 through 2004 for uses not approved by the U.S. Food and Drug Administration, according to Schneiderman.
In reaching the accord, J&J agreed it wouldn’t promote the drugs for off-label uses or make false claims about them.
“This landmark settlement holds the companies accountable for practices that put patients in danger, and serves as a warning to other pharmaceutical giants that they must play by one set of rules,” Schneiderman said in a statement.
Schneiderman said the agreement is the largest multistate consumer protection-based pharmaceutical settlement."
Hiç yorum yok:
Yorum Gönder